Works matching IS 00071048 AND DT 2010 AND VI 151 AND IP 2


Results: 16
    1
    2

    The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 167, doi. 10.1111/j.1365-2141.2010.08316.x
    By:
    • Buchner, Maike;
    • Brantner, Philipp;
    • Stickel, Natalie;
    • Prinz, Gabriele;
    • Burger, Meike;
    • Bär, Constance;
    • Dierks, Christine;
    • Pfeifer, Dietmar;
    • Ott, Ariane;
    • Mertelsmann, Roland;
    • Gribben, John G.;
    • Veelken, Hendrik;
    • Zirlik, Katja
    Publication type:
    Article
    3
    4
    5

    Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 152, doi. 10.1111/j.1365-2141.2010.08339.x
    By:
    • Goldin, Lynn R.;
    • Lanasa, Mark C.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Vachon, Celine M.;
    • Strom, Sara S.;
    • Camp, Nicola J.;
    • Spector, Logan G.;
    • Leis, Jose F.;
    • Morrison, Vicki A.;
    • Glenn, Martha;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Algood, Sallie D.;
    • Abbasi, Fatima;
    • Fontaine, Laura;
    • Yau, Michelle;
    • Rassenti, Laura Z.;
    • Kay, Neil E.;
    • Call, Timothy G.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 143, doi. 10.1111/j.1365-2141.2010.08331.x
    By:
    • Advani, Ranjana H.;
    • Chen, Haiyan;
    • Habermann, Thomas M.;
    • Morrison, Vicki A.;
    • Weller, Edie A.;
    • Fisher, Richard I.;
    • Peterson, Bruce A.;
    • Gascoyne, Randy D.;
    • Horning, Sandra J.
    Publication type:
    Article
    12
    13
    14

    Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 2, p. 159, doi. 10.1111/j.1365-2141.2010.08329.x
    By:
    • Simon, Audrey;
    • Peoch, Michel;
    • Casassus, Philippe;
    • Deconinck, Eric;
    • Colombat, Philippe;
    • Desablens, Bernard;
    • Tournilhac, Olivier;
    • Eghbali, Houchingue;
    • Foussard, Charles;
    • Jaubert, Jerome;
    • Vilque, Jean Pierre;
    • Rossi, Jean François;
    • Lucas, Virginie;
    • Delwail, Vincent;
    • Thyss, Antoine;
    • Maloisel, Frederic;
    • Milpied, Noel;
    • Le Gouill, Steven;
    • Lamy, Thierry;
    • Gressin, Rémy
    Publication type:
    Article
    15
    16